NewsRx

Search our medical news database

Pancreatic Cancer Therapy

Gene transfer shuts down pancreatic tumors in cancer models

Published in Cancer Weekly, December 17th, 2002

by Sonia Nichols, senior medical writer - Scientists in France report encouraging results in pancreatic cancer models treated with gene therapy.

Researchers who work for INSERM in Toulouse, France, used somatostatin receptor subtype 2 (sst2) gene therapy to subdue both primary and metastatic human pancreatic cancer lesions growing in immunocompromised mice. Sst2 has antioncogenic properties with a reach that extends beyond tumors treated locally, according to a new report.

Fabienne Vernejoul and colleagues said the sst2 genes, when delivered to cancer cells via adenovirus or a synthetic polycationic carrier (PEI), generated transgene expression at...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook